Ultra-Delayed Intracardiac Cement Embolism After Percutaneous Vertebroplasty: A Case Report and Review of Management Strategies

Summary

A rare case of ultra-delayed intracardiac bone cement embolism detected 2.5 years after vertebroplasty is presented. Diagnostic imaging, surgical removal under cardiopulmonary bypass, and concurrent coronary artery bypass grafting are demonstrated.

Abstract

Cardiac cement embolism is a rare but potentially life-threatening complication of percutaneous vertebroplasty, usually occurring during or shortly after the procedure. Delayed presentations remain poorly recognized. Here, we report a rare case of intracardiac bone cement embolism 2.5 years after vertebroplasty. A 76-year-old man with a history of lumbar vertebroplasty presented with progressive exercise intolerance and intermittent chest pain. Transthoracic echocardiography and cardiac computed tomography angiography revealed three rod-shaped, high-density foreign bodies in the right ventricle, one of which was embedded in the ventricular myocardium. Coronary angiography demonstrated severe stenosis of the left anterior descending artery. Given the risks of cardiac perforation and coexisting coronary artery disease, simultaneous surgical removal of the cement emboli and coronary artery bypass grafting were performed under cardiopulmonary bypass. All foreign bodies were successfully removed, and the right ventricular wall was reinforced. The patient recovered uneventfully, with resolution of symptoms and preserved cardiac function during 6 months of follow-up. This report highlights the possibility of ultra-delayed and asymptomatic intracardiac cement embolism after vertebroplasty. Long-term cardiovascular surveillance may be warranted in patients with a history of vertebroplasty presenting with unexplained cardiopulmonary symptoms. Although earlier post-vertebroplasty imaging was unavailable, the embolic route likely traversed the pulmonary circulation before lodging in the right ventricle. Given the asymptomatic latency, selective chest imaging may aid early detection in patients with high-risk leakage patterns, though routine screening remains impractical.

Introduction

Percutaneous vertebroplasty (PVP) is a widely used minimally invasive procedure for the treatment of osteoporotic vertebral compression fractures. By injecting polymethylmethacrylate bone cement into the collapsed vertebral body, PVP effectively restores vertebral stability and provides rapid pain relief¹. Despite its clinical benefits, cement leakage remains a recognized complication, with reported incidences varying widely depending on detection methods and cement properties².

Most cement leakage events are clinically silent and confined to paravertebral soft tissue, intervertebral discs, or the spinal canal³. However, in rare circumstances, cement can enter the vertebral venous plexus and migrate through the inferior vena cava to the pulmonary arteries or cardiac chambers, resulting in pulmonary or cardiac cement embolism⁴. Among these complications, cardiac cement embolism is particularly rare, accounting for approximately 0.1%–0.5% of PVP-related adverse events, but it carries a high risk of severe outcomes such as cardiac perforation, tamponade, arrhythmia, and shock⁵. Diagnosis hinges on integrating procedural history with imaging hallmarks: cement emboli appear as linear/rod-shaped hyperdensities (≥1,000 Hounsfield units) on computed tomography (CT), distinct from thrombus, myxoma, or calcified vegetation. Differential diagnosis includes right-sided thromboembolism, metastatic seeding, or retained catheter fragments, but vertebroplasty history and fragment morphology prioritize cement embolism⁶.

Previous reports indicate that cardiac cement embolism typically presents acutely or subacutely, occurring intraoperatively or within hours to several months after PVP⁶. Clinical manifestations may include sudden chest pain, dyspnoea, or hemodynamic instability, often prompting emergency intervention^4,5. In contrast, delayed or asymptomatic intracardiac cement embolism remains poorly recognized, and cases discovered years after the initial procedure are extremely rare. Potential mechanisms for such ultra-delayed presentation remain underexplored but may involve gradual fragmentation and slow migration of residual paravertebral cement, alongside myocardial adaptive changes, including fibrosis and encapsulation, that transiently mitigate arrhythmogenic or perforation risks despite chronic foreign-body presence^7,8.

In addition, there is currently no consensus regarding optimal diagnostic strategies or management algorithms for intracardiac cement embolism. Treatment options reported in the literature range from conservative observation and anticoagulation therapy to percutaneous retrieval or open surgical removal, depending on the size, location, and clinical impact of the cement fragment^9,10,11,12.

Unlike most reported cases of acute or subacute embolism, this report documents an ultra-delayed (>2 years), initially asymptomatic intracardiac cement embolism managed surgically in combination with coronary artery bypass grafting (CABG). Our objectives are to (1) detail the multimodal diagnostic pathway for late-presenting intracardiac cement emboli; (2) demonstrate a one-stage surgical strategy for concomitant cement removal and CABG, avoiding staged interventions; and (3) highlight the need for long-term vigilance even years after vertebroplasty, an aspect less emphasized in prior literature focused on perioperative complications.

Case presentation​:
This study describes a 76-year-old man with a history of lumbar vertebroplasty who presented with progressive exercise intolerance and intermittent chest pain 2.5 years post-procedure. Initial evaluation revealed no acute cardiopulmonary decompensation, but subsequent imaging identified unexpected intracardiac foreign bodies alongside significant coronary artery disease (CAD).

Diagnosis, treatment, and plan:​
Multimodal imaging, comprising transthoracic echocardiography, cardiac CT angiography, and coronary angiography, identified three rod-shaped cement emboli within the right ventricle, with one embedded in the myocardium, alongside severe stenosis of the left anterior descending (LAD) artery. Following multidisciplinary consultation, a single-stage surgical strategy was devised: removal of intracardiac cement under cardiopulmonary bypass (CPB) combined with CABG to address both pathologies simultaneously.

Protocol

This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of The Second People's Hospital of Liaocheng (approval number: XY2024-LC-038). Written informed consent was obtained from the patient for publication of this case report and accompanying images. The steps of the protocol are presented in Supplementary Figure 1.

1. Preoperative evaluation

1. Transthoracic echocardiography was performed to identify intracardiac foreign bodies and assess cardiac function.
2. Cardiac CT angiography was conducted to determine the size, shape, and location of cement emboli. As illustrated in Figure 1, intracardiac cement embolism was confirmed, and thrombus or tumor was ruled out by these CT findings.
3. Coronary angiography was performed to evaluate concomitant CAD. The dual pathology was established in Figure 2, and severe LAD artery stenosis alongside radiopaque cement fragments was shown.
4. A multidisciplinary consultation was conducted, involving cardiology, cardiac surgery, radiology, and orthopedics. The embolic origin was traced to paravertebral cement leakage adjacent to the lumbar spine in Figure 3.
   1. Embolus mobility and myocardial involvement were assessed on imaging; whether symptoms correlated more with cement irritation or underlying coronary disease was evaluated; and the risks of combined versus staged surgery were compared. Single-stage cement removal plus CABG was performed if the embolus showed high-risk embedding and the coronary lesions were suitable for concurrent repair.

2. Surgical preparation

1. Standard preoperative sedation was administered, and general anesthesia was induced with endotracheal intubation; adequate ventilation and oxygenation were confirmed via .capnography and pulse oximetry.
2. Invasive hemodynamic monitoring, including an arterial blood pressure catheter, a central venous catheter, and continuous electrocardiography, was established, and activated clotting time (ACT) was monitored throughout the procedure.
3. CPB equipment, including the oxygenator, arterial filter, and cardioplegia delivery system, was prepared and tested, and the ready availability of microsurgical instruments, bipolar cautery, and ventricular wall repair materials was ensured.
4. A median sternotomy was performed by dividing the sternum vertically; the sternal edges were retracted widely to achieve clear exposure of the pericardium and anterior mediastinal structures.
5. The pericardium was incised longitudinally and suspended to the sternal edges to achieve full exposure of the ascending aorta, both venae cavae, the right atrium, and the right ventricle.
6. The left internal mammary artery (LIMA) was harvested as a bypass graft with careful dissection to preserve blood flow and avoid injury to adjacent structures; the harvested LIMA was wrapped in moist, papaverine-soaked gauze to prevent spasm.

3. Cardiopulmonary bypass and cardiac arrest

1. Systemic heparin sodium was administered at a dose of 300–400 IU/kg to achieve an ACT > 480 s; the ACT was confirmed with point-of-care testing before cannulation.
2. The ascending aorta was cannulated with an arterial cannula; bicaval cannulation was performed via. the right atrium, targeting the superior and inferior venae cavae, to establish full CPB.
3. CPB was initiated with gradual blood flow adjustment to maintain stable systemic perfusion; the patient was cooled to 32–34 °C (systemic hypothermia) for myocardial protection.
4. An aortic cross-clamp was placed across the ascending aorta proximal to the arterial cannula; cold crystalloid cardioplegia (4 °C) was administered into the aortic root at a dose of 15–20 mL/kg to induce rapid electromechanical cardiac arrest.
5. The cardioplegia infusion was repeated every 20–30 min, or as needed, to maintain myocardial hypothermia and electromechanical silence; myocardial temperature was monitored continuously.

4. Removal of intracardiac cement emboli

1. The location of the right ventricular (RV) cement fragments was confirmed using direct visual inspection and intraoperative transoesophageal echocardiography (TEE); the embedded fragment was mapped against the RV free wall.
2. A limited right ventriculotomy was made at a site remote from the embedded cement fragment to avoid additional myocardial injury; gentle traction and retraction were used to expose the three rod-shaped, high-density cement emboli.
3. For the fragment embedded in the ventricular myocardium, the surrounding myocardial fibers were dissected sharply with microscissors to free the cement without forceful manipulation; scraping or avulsing the adjacent myocardium was avoided.
4. All three cement emboli were extracted completely using microsurgical forceps; complete removal was verified by direct inspection and TEE to rule out residual fragments. The successful retrieval of all intracardiac cement emboli was validated in Figure 4, with morphology matching preoperative imaging.
5. The RV wall was repaired by placing interrupted mattress sutures with felt reinforcement to prevent bleeding and strengthen the area of previous cement embedding; the ventriculotomy was closed securely in layers.
6. The tricuspid valve apparatus and RV cavity were inspected carefully to confirm no damage to valvular structures or residual foreign material.

5. Coronary artery bypass grafting

1. The severely stenosed segment of the LAD artery distal to the lesion was identified; the target vessel was prepared by opening the arteriotomy with a microknife and dilating gently.​
2. An end-to-side anastomosis was performed between the distal end of the harvested LIMA graft and the LAD artery using continuous 7–0 polypropylene sutures; precise suture placement was ensured to avoid graft stenosis or bleeding.​
3. The anastomosis was tested for patency and hemostasis by releasing gentle blood flow through the graft; no leakage at the anastomotic site was confirmed.​
4. Myocardial protection was maintained during grafting with intermittent cold cardioplegia as needed; the surgical field was kept clear and bloodless for accurate anastomosis.

6. Weaning from bypass and closure

1. The patient was rewarmed gradually to 36–37 °C (systemic normothermia) while on CPB; spontaneous cardiac electrical activity was restored by defibrillation if necessary.​
2. Inotropic and vasoactive medications were adjusted to maintain adequate blood pressure and cardiac output; the patient was weaned from CPB slowly under TEE guidance.​
3. Protamine sulfate was administered to reverse heparinization, typically at a 1:1 ratio based on the initial heparin dose, and the ACT was normalized to confirm adequate hemostasis.​
4. One pericardial drainage tube and one mediastinal drainage tube were placed to evacuate residual fluid and prevent tamponade; all tubes were secured firmly.​
5. The sternum was closed with multiple stainless steel wires; the subcutaneous tissue and skin were approximated in layers with absorbable and non-absorbable sutures, respectively.

7. Postoperative management and follow-up

1. The patient was admitted to the cardiac intensive care unit (ICU) for continuous hemodynamic, electrocardiographic, and respiratory monitoring. Hourly vital signs, chest tube output, and urine output were recorded. Cardiac biomarkers, blood count, coagulation, and electrolytes were checked daily.​
2. Long-term aspirin and short-term clopidogrel were prescribed for graft patency. Prophylactic antibiotics, beta-blockers, and statins were used as routine postoperative therapy.​
3. Transthoracic echocardiography was performed within 24 h postoperatively to confirm complete cement removal and normal cardiac function. Chest radiographs were obtained until drain removal.​
4. The patient was discharged when clinically stable. Follow-up was scheduled at 6 months with clinical assessment and echocardiography. Prompt reporting of any new cardiopulmonary symptoms was advised.

Results

Diagnostic imaging confirmed three rod-shaped intracardiac cement emboli, with one embedded in the RV myocardium, and severe LAD artery stenosis, with paravertebral cement suggesting a venous migration route. All emboli were successfully removed via. CPB-assisted right ventriculotomy, followed immediately by LIMA-to-LAD grafting. The total operative duration was 215 min, with a CPB time of 112 min and an aortic cross-clamp time of 78 min. The patient was extubated on postoperative day 1 and transferred from the ...

Discussion

Cardiac cement embolism is a rare but serious complication of PVP. Most reported cases occur acutely or within a short period after surgery and are associated with obvious cardiopulmonary symptoms^4,5,7. In contrast, the present case demonstrates that intracardiac cement embolism can remain asymptomatic for an extended period and be detected more than 2 years after the initial procedure, expanding the known clinical spectrum of t...

Materials

List of materials used in this article

Name	Company	Catalog Number	Comments
Aspirin	Bayer	www.bayer.com	Antiplatelet agent used to maintain coronary graft patency
Beta-blocker	Institution-specific supplier	www.astrazeneca.com	Used for postoperative cardiovascular protection
Cardiopulmonary bypass system	Getinge	www.getinge.com/int/products/extracorporeal-life-support/cardiopulmonary-bypass/	Full perfusion system with oxygenator and arterial filter
Clopidogrel	Sanofi	www.sanofi.com	Used for short-term dual antiplatelet therapy
Cold crystalloid cardioplegia solution	Institution-specific supplier	N/A	Used for myocardial protection and induction of cardiac arrest
Heparin sodium	Pfizer	NDC 0069-0057-01*	Systemic anticoagulant used during cardiopulmonary bypass
Left internal mammary artery harvest set	Medtronic	www.medtronic.com	Instruments used for harvesting the left internal mammary artery
Microknife	Fine Science Tools	10056-12	Used for coronary arteriotomy and fine surgical dissection
Microscissors	Fine Science Tools	14060-09	Used for sharp dissection around embedded cement fragments
Microsurgical forceps	Fine Science Tools	11003-12	Used for extraction of intracardiac cement emboli
Papaverine hydrochloride	Pfizer	www.pfizer.com	Applied to prevent left internal mammary artery graft spasm
Polymethylmethacrylate (PMMA) bone cement	Heraeus Medical	66004906 (PALACOS R+G)	Bone cement used during vertebroplasty
Polypropylene suture, 7-0	Ethicon	8701H (PROLENE 7-0)	Used for left internal mammary artery-to-left anterior descending artery anastomosis
Protamine sulfate	Pfizer	NDC 0069-0925-01	Used to reverse heparinization after cardiopulmonary bypass
Statin	Institution-specific supplier	www.pfizer.com	Used for long-term secondary prevention after coronary artery bypass grafting
Surgical felt pledgets	B. Braun	1021355	Used for reinforcement of right ventricular wall repair
Transesophageal echocardiography system	GE HealthCare	www.gehealthcare.com/products/ultrasound/cardiovascular-ultrasound	Used intraoperatively to localize cement emboli and confirm complete removal